60% off Profit Pro - Limited Time Offer!
34.17MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA00430K8730
CUSIP
00430K105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.86
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.43
Wall Street Target Price
7.97
EPS Estimate Current Year
-1.44
EPS Estimate Next Year
-1.12
EPS Estimate Current Quarter
-0.25
EPS Estimate Next Quarter
-0.31
Most Recent Quarter
-
Revenue TTM
115,000
Gross Profit TTM
120,000
EBITDA
-13,266,000
Profit Margin
0.00%
Return On Assets TTM
-11.62%
Return On Equity TTM
-18.56%
Revenue Per Share TTM
0.005
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-1.43
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
208.3872
Price Book MRQ
0.5295
Enterprise Value Revenue
5
Enterprise Value EBITDA
0
185.00
1.86%88.70
1.04%410.66
0.67%632.04
0.33%716.68
0.31%173.50
0.00%198.28
0.00%99.02
-0.96%242.00
-0.60%113.80
-0.10%See which Billionaires own this investment